Loading...
•
Dec 31, 2022
Pulmonx Q4 2022 Earnings Report
Pulmonx reported record worldwide revenue and U.S. revenue for the fourth quarter of 2022.
Key Takeaways
Pulmonx Corporation reported a 13% increase in worldwide revenue for the fourth quarter of 2022, reaching a record $15.4 million. U.S. revenue also hit a record of $9.5 million, a 30% increase year-over-year. The company's gross margin was 73% for the quarter.
Delivered $53.7 million in worldwide revenue for the full year of 2022.
Achieved record worldwide revenue of $15.4 million for the fourth quarter of 2022, a 13% increase over the same period last year.
Set a new record of $32.5 million and $9.5 million in U.S. revenue for the full year 2022 and the fourth quarter 2022 respectively, each representing 30% year-over-year growth.
Realized gross margin of 73% in the fourth quarter of 2022 and 74% for the full year of 2022.
Forward Guidance
Pulmonx expects revenue for the full year 2023 to be in the range of $63 million to $65 million. The Company expects gross margin for the full year 2023 to fall within the range of 73% to 74%. Pulmonx expects total operating expenses for the full year 2023 to fall within the range of $112 million to $114 million, inclusive of approximately $22 million of non-cash stock-based compensation.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...